Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAESTRO: Triflusal vs Clopidogrel for Stroke Prevention in CYP2C19 Metabolizers
NCT01174693Phase 4Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Mar 2010
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Triflusal in ischemic stroke, sponsored by Gangnam Severance Hospital. Started Mar 2010; status: completed.
02
Drugs
Triflusal
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01174693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174693.